Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pollak

Showing results (291-300 of 326) with videos related to

Pageof 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2014
Evolution of the primate trypanolytic factor APOL1Russell Thomson, Giulio Genovese, Chelsea Canon, et al.
Kidney International Reports|January 1, 2019
The Glomerular Disease Study and Trial Consortium: A Grassroots Initiative to Foster Collaboration and InnovationAli Poyan Mehr, Maryam Sadeghi-Najafabadi, Kristi Chau, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
<i>UBD</i> modifies <i>APOL1</i>-induced kidney disease riskJia-Yue Zhang, Minxian Wang, Lei Tian, et al.
BMC Nephrology|October 1, 2008
NPHS2 variation in focal and segmental glomerulosclerosisStephen J Tonna, Alexander Needham, Krishna Polu, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
Genetic variation in APOL1 associates with younger age at hemodialysis initiationZahra Kanji, Camille E Powe, Julia B Wenger, et al.
American Journal of Physiology. Cell Physiology|December 3, 2010
Biophysical properties of normal and diseased renal glomeruliHans M Wyss, Joel M Henderson, Fitzroy J Byfield, et al.
Journal of the American Society of Nephrology : JASN|November 2, 2025
Testican-2 Interaction with the Extracellular Matrix and Podocyte ProtectionDonghai Wen, Qian Zhang, Johannes van Agthoven, et al.
Pflugers Archiv : European Journal of Physiology|November 30, 2022
Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytesDavid H Vandorpe, John F Heneghan, Joshua S Waitzman, et al.
Disease Models & Mechanisms|August 5, 2021
Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney diseaseGizelle M McCarthy, Angelo Blasio, Olivia G Donovan, et al.
Journal of the American Society of Nephrology : JASN|June 17, 2020
Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric GlomerulosclerosisDi Feng, Mukesh Kumar, Jan Muntel, et al.
Pageof 33

Showing results (291-300 of 326) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2014
Evolution of the primate trypanolytic factor APOL1Russell Thomson, Giulio Genovese, Chelsea Canon, et al.
Kidney International Reports|January 1, 2019
The Glomerular Disease Study and Trial Consortium: A Grassroots Initiative to Foster Collaboration and InnovationAli Poyan Mehr, Maryam Sadeghi-Najafabadi, Kristi Chau, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
<i>UBD</i> modifies <i>APOL1</i>-induced kidney disease riskJia-Yue Zhang, Minxian Wang, Lei Tian, et al.
BMC Nephrology|October 1, 2008
NPHS2 variation in focal and segmental glomerulosclerosisStephen J Tonna, Alexander Needham, Krishna Polu, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
Genetic variation in APOL1 associates with younger age at hemodialysis initiationZahra Kanji, Camille E Powe, Julia B Wenger, et al.
American Journal of Physiology. Cell Physiology|December 3, 2010
Biophysical properties of normal and diseased renal glomeruliHans M Wyss, Joel M Henderson, Fitzroy J Byfield, et al.
Journal of the American Society of Nephrology : JASN|November 2, 2025
Testican-2 Interaction with the Extracellular Matrix and Podocyte ProtectionDonghai Wen, Qian Zhang, Johannes van Agthoven, et al.
Pflugers Archiv : European Journal of Physiology|November 30, 2022
Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytesDavid H Vandorpe, John F Heneghan, Joshua S Waitzman, et al.
Disease Models & Mechanisms|August 5, 2021
Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney diseaseGizelle M McCarthy, Angelo Blasio, Olivia G Donovan, et al.
Journal of the American Society of Nephrology : JASN|June 17, 2020
Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric GlomerulosclerosisDi Feng, Mukesh Kumar, Jan Muntel, et al.
Pageof 33